Glial cells in Alzheimer’s disease: From neuropathological changes to therapeutic implications

This publication has 236 references indexed in Scilit:

• Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model
  Proceedings of the National Academy of Sciences, 2012
• Astrocytes Secrete Exosomes Enriched with Proapoptotic Ceramide and Prostate Apoptosis Response 4 (PAR-4)
  Journal of Biological Chemistry, 2012
• Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease
  Journal of Biological Chemistry, 2012
• Calcium Dysregulation and Homeostasis of Neural Calcium in the Molecular Mechanisms of Neurodegenerative Diseases Provide Multiple Targets for Neuroprotection
  Antioxidants & Redox Signaling, 2011
• Epidemiology of Alzheimer disease
  Nature Reviews Neurology, 2011
• YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease
  Biological Psychiatry, 2010
• Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease
  Neurobiology of Aging, 2010
• The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
  Nature Immunology, 2010
• Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little?
  Neuron, 2009
• Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
  Glia, 2007